Skip to main content
# Title Department Research Year
1 Fatty Acid Conjugated Chalcones as Tubulin Polymerization Inhibitors: Design, Synthesis, QSAR, and Apoptotic and Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 26/4/2023
2 Disposable and sensitive electrochemical magneto-immunosensor for point-of-care HCV diagnostics: Targeting HCVcAg, the active viremia biomarker, in patient samples Department of Pharmaceutical Analytical Chemistry 2025
3 N-substituted-5-[(2,5-dihydroxybenzyl)amino]salicylamides as lavendustin analogs: antiproliferative activity, COMPARE analyses, mechanistic, docking, ADMET and toxicity studies Department of Pharmaceutical Organic Chemistry 2025
4 Cobalt-induced oxidative stress and defense responses of Adhatoda vasica proliferated shoots Department of Pharmacognosy 2025
5 Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review Department of Microbiology and Immunology 2024
6 Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities Department of Medicinal Chemistry 2024
7 Developing a switch “OFF-ON” fluorescent probe for detection of melamine based on doubly-protected red emissive copper nanoclusters mediated by Hg2+ ions Department of Pharmaceutical Analytical Chemistry 2024
8 Highly selective fluorometric detection of streptokinase via fibrinolytic release of photoluminescent carbon dots integrated into fibrin clot network Department of Pharmaceutical Analytical Chemistry 2024
9 Design and synthesis new dihydropyrimidine derivatives with cytotoxic effect as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
10 Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024